Skip to content

Goodwill at other companies

Stryker logo
StrykerSYK
$19.19B+0.5%
Boston Scientific logo
Boston ScientificBSX
$18.54B+6.9%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$19.77M-8.1%
Medtronic logo
MedtronicMDT
$42.59B+2.0%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$145.93M-3.2%
Cardinal Health logo
Cardinal HealthCAH

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B+108%
Enterprise value$1.24B+105%
P/S1.6×+0.8×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's goodwill?
Avanos Medical (AVNS) reported goodwill of $394M in Q1 2026.
How has Avanos Medical's goodwill changed year-over-year?
Avanos Medical's goodwill decreased by 13.6% year-over-year, from $455.9M to $394M.
What is the long-term trend for Avanos Medical's goodwill?
Over 5 years (2020 to 2025), Avanos Medical's goodwill has grown at a -13.2% compound annual growth rate (CAGR), from $802.5M to $394.9M.
What does goodwill mean?
The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.